CLDX FY 2016 Earnings — Celldex Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CLDXCelldex Therapeutics, Inc.

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+23.8% YoY

Gross Profit

-$95M-1403.5% margin

Operating Income

-$133M-1958.7% margin

Net Income

-$129M-1894.0% margin

EPS (Diluted)

$-18.99

Cash Flow

Operating Cash Flow

-$113M

Free Cash Flow

-$116M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$383M

Total Liabilities

$118M

Stockholders' Equity

$265M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$5M	+23.8%
Gross Profit	-$95M	$1M	-6583.3%
Operating Income	-$133M	-$130M	-2.6%
Net Income	-$129M	-$127M	-1.0%